APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fluphenazine Decanoate

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Fluphenazine Decanoate Market Outlook and Growth Opportunities 2026

19 December 2025191 pages

Choose your research edition.

Industry ResearchFluphenazine Decanoate Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Fluphenazine Decanoate Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Fluphenazine Decanoate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fluphenazine Decanoate Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Fluphenazine Decanoate Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Fluphenazine Decanoate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Fluphenazine Decanoate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fluphenazine Decanoate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fluphenazine Decanoate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Fluphenazine Decanoate market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Fluphenazine Decanoate market include Atlantic Laboratories Corporation,Ltd., AUROBINDO PHARMA LTD, FRESENIUS KABI USA, MYLAN LABS LTD, PAR STERILE PRODUCTS, WEST-WARD PHARMS INT, Shanghai Harvest Pharmaceutical, Shanghai Zhongxi Sunve Pharmaceutical and Southwest Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Fluphenazine Decanoate market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fluphenazine Decanoate and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fluphenazine Decanoate revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Fluphenazine Decanoate market.

Fluphenazine Decanoate Segment by Company

Atlantic Laboratories Corporation,Ltd.

AUROBINDO PHARMA LTD

FRESENIUS KABI USA

MYLAN LABS LTD

PAR STERILE PRODUCTS

WEST-WARD PHARMS INT

Shanghai Harvest Pharmaceutical

Shanghai Zhongxi Sunve Pharmaceutical

Southwest Pharmaceutical

Fluphenazine Decanoate Segment by Type

Acute Schizophrenia

Chronic Schizophrenia

Others

Fluphenazine Decanoate Segment by Application

Children

Adult

Fluphenazine Decanoate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Fluphenazine Decanoate status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Fluphenazine Decanoate key companies, revenue, market share, and recent developments.

3. To split the Fluphenazine Decanoate breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Fluphenazine Decanoate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Fluphenazine Decanoate significant trends, drivers, influence factors in global and regions.

6. To analyze Fluphenazine Decanoate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fluphenazine Decanoate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fluphenazine Decanoate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fluphenazine Decanoate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fluphenazine Decanoate industry.

Chapter 3: Detailed analysis of Fluphenazine Decanoate company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Fluphenazine Decanoate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Fluphenazine Decanoate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Fluphenazine Decanoate Industry Trends Table 2. Fluphenazine Decanoate Industry Drivers Table 3. Fluphenazine Decanoate Industry Opportunities and Challenges Table 4. Fluphenazine Decanoate Industry Restraints Table 5. Global Fluphenazine Decanoate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Fluphenazine Decanoate Revenue Share by Company (2021-2026) Table 7. Global Fluphenazine Decanoate Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Fluphenazine Decanoate Key Company Manufacturing Base & Headquarters Table 9. Global Fluphenazine Decanoate Company, Product Type & Application Table 10. Global Fluphenazine Decanoate Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Fluphenazine Decanoate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Acute Schizophrenia Table 15. Significant Companies of Chronic Schizophrenia Table 16. Significant Companies of Others Table 17. Global Fluphenazine Decanoate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Fluphenazine Decanoate Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Fluphenazine Decanoate Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Fluphenazine Decanoate Sales Value Share by Type (2021-2026) Table 21. Global Fluphenazine Decanoate Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Children Table 23. Significant Companies of Adult Table 24. Global Fluphenazine Decanoate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Fluphenazine Decanoate Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Fluphenazine Decanoate Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Fluphenazine Decanoate Sales Value Share by Application (2021-2026) Table 28. Global Fluphenazine Decanoate Sales Value Share by Application (2027-2032) Table 29. Global Fluphenazine Decanoate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Fluphenazine Decanoate Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Fluphenazine Decanoate Sales Value Share by Region (2021-2026) Table 32. Global Fluphenazine Decanoate Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Fluphenazine Decanoate Sales Value Share by Region (2027-2032) Table 34. Global Fluphenazine Decanoate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Fluphenazine Decanoate Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Fluphenazine Decanoate Sales Value Market Share by Country (2021-2026) Table 37. Global Fluphenazine Decanoate Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Fluphenazine Decanoate Sales Value Market Share by Country (2027-2032) Table 39. Atlantic Laboratories Corporation,Ltd. Company Information Table 40. Atlantic Laboratories Corporation,Ltd. Business Overview Table 41. Atlantic Laboratories Corporation,Ltd. Fluphenazine Decanoate Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Atlantic Laboratories Corporation,Ltd. Fluphenazine Decanoate Product Portfolio Table 43. Atlantic Laboratories Corporation,Ltd. Recent Development Table 44. AUROBINDO PHARMA LTD Company Information Table 45. AUROBINDO PHARMA LTD Business Overview Table 46. AUROBINDO PHARMA LTD Fluphenazine Decanoate Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. AUROBINDO PHARMA LTD Fluphenazine Decanoate Product Portfolio Table 48. AUROBINDO PHARMA LTD Recent Development Table 49. FRESENIUS KABI USA Company Information Table 50. FRESENIUS KABI USA Business Overview Table 51. FRESENIUS KABI USA Fluphenazine Decanoate Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. FRESENIUS KABI USA Fluphenazine Decanoate Product Portfolio Table 53. FRESENIUS KABI USA Recent Development Table 54. MYLAN LABS LTD Company Information Table 55. MYLAN LABS LTD Business Overview Table 56. MYLAN LABS LTD Fluphenazine Decanoate Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. MYLAN LABS LTD Fluphenazine Decanoate Product Portfolio Table 58. MYLAN LABS LTD Recent Development Table 59. PAR STERILE PRODUCTS Company Information Table 60. PAR STERILE PRODUCTS Business Overview Table 61. PAR STERILE PRODUCTS Fluphenazine Decanoate Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. PAR STERILE PRODUCTS Fluphenazine Decanoate Product Portfolio Table 63. PAR STERILE PRODUCTS Recent Development Table 64. WEST-WARD PHARMS INT Company Information Table 65. WEST-WARD PHARMS INT Business Overview Table 66. WEST-WARD PHARMS INT Fluphenazine Decanoate Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. WEST-WARD PHARMS INT Fluphenazine Decanoate Product Portfolio Table 68. WEST-WARD PHARMS INT Recent Development Table 69. Shanghai Harvest Pharmaceutical Company Information Table 70. Shanghai Harvest Pharmaceutical Business Overview Table 71. Shanghai Harvest Pharmaceutical Fluphenazine Decanoate Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Shanghai Harvest Pharmaceutical Fluphenazine Decanoate Product Portfolio Table 73. Shanghai Harvest Pharmaceutical Recent Development Table 74. Shanghai Zhongxi Sunve Pharmaceutical Company Information Table 75. Shanghai Zhongxi Sunve Pharmaceutical Business Overview Table 76. Shanghai Zhongxi Sunve Pharmaceutical Fluphenazine Decanoate Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Shanghai Zhongxi Sunve Pharmaceutical Fluphenazine Decanoate Product Portfolio Table 78. Shanghai Zhongxi Sunve Pharmaceutical Recent Development Table 79. Southwest Pharmaceutical Company Information Table 80. Southwest Pharmaceutical Business Overview Table 81. Southwest Pharmaceutical Fluphenazine Decanoate Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Southwest Pharmaceutical Fluphenazine Decanoate Product Portfolio Table 83. Southwest Pharmaceutical Recent Development Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. Fluphenazine Decanoate Product Image Figure 2. Global Fluphenazine Decanoate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fluphenazine Decanoate Market Size (2021-2032) & (US$ Million) Figure 4. Global Fluphenazine Decanoate Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Acute Schizophrenia Image Figure 8. Chronic Schizophrenia Image Figure 9. Others Image Figure 10. Global Fluphenazine Decanoate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Fluphenazine Decanoate Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Fluphenazine Decanoate Sales Value Share by Type (2021-2032) Figure 13. Children Image Figure 14. Adult Image Figure 15. Global Fluphenazine Decanoate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Fluphenazine Decanoate Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Fluphenazine Decanoate Sales Value Share by Application (2021-2032) Figure 18. Global Fluphenazine Decanoate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Fluphenazine Decanoate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Fluphenazine Decanoate Sales Value (2021-2032) & (US$ Million) Figure 21. North America Fluphenazine Decanoate Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Fluphenazine Decanoate Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Fluphenazine Decanoate Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Fluphenazine Decanoate Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Fluphenazine Decanoate Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Fluphenazine Decanoate Sales Value (2021-2032) & (US$ Million) Figure 27. South America Fluphenazine Decanoate Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Fluphenazine Decanoate Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Fluphenazine Decanoate Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Fluphenazine Decanoate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Acute Schizophrenia
  • Chronic Schizophrenia
  • Others
Applications
  • Children
  • Adult
Companies covered
  • Atlantic Laboratories Corporation,Ltd.
  • AUROBINDO PHARMA LTD
  • FRESENIUS KABI USA
  • MYLAN LABS LTD
  • PAR STERILE PRODUCTS
  • WEST-WARD PHARMS INT
  • Shanghai Harvest Pharmaceutical
  • Shanghai Zhongxi Sunve Pharmaceutical
  • Southwest Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Fluphenazine Decanoate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Fluphenazine Decanoate Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Fluphenazine Decanoate Market Dynamics
  1. 2.1 Fluphenazine Decanoate Industry Trends
  2. 2.2 Fluphenazine Decanoate Industry Drivers
  3. 2.3 Fluphenazine Decanoate Industry Opportunities and Challenges
  4. 2.4 Fluphenazine Decanoate Industry Restraints
3 Fluphenazine Decanoate Market by Company
  1. 3.1 Global Fluphenazine Decanoate Company Revenue Ranking in 2025
  2. 3.2 Global Fluphenazine Decanoate Revenue by Company (2021-2026)
  3. 3.3 Global Fluphenazine Decanoate Company Ranking (2024-2026)
  4. 3.4 Global Fluphenazine Decanoate Company Manufacturing Base and Headquarters
  5. 3.5 Global Fluphenazine Decanoate Company Product Type and Application
  6. 3.6 Global Fluphenazine Decanoate Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Fluphenazine Decanoate Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Fluphenazine Decanoate Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Fluphenazine Decanoate Market by Type
  1. 4.1 Fluphenazine Decanoate Type Introduction
  2. 4.1.1 Acute Schizophrenia
  3. 4.1.2 Chronic Schizophrenia
  4. 4.1.3 Others
  5. 4.2 Global Fluphenazine Decanoate Sales Value by Type
  6. 4.2.1 Global Fluphenazine Decanoate Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Fluphenazine Decanoate Sales Value by Type (2021-2032)
  8. 4.2.3 Global Fluphenazine Decanoate Sales Value Share by Type (2021-2032)
5 Fluphenazine Decanoate Market by Application
  1. 5.1 Fluphenazine Decanoate Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adult
  4. 5.2 Global Fluphenazine Decanoate Sales Value by Application
  5. 5.2.1 Global Fluphenazine Decanoate Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Fluphenazine Decanoate Sales Value by Application (2021-2032)
  7. 5.2.3 Global Fluphenazine Decanoate Sales Value Share by Application (2021-2032)
6 Fluphenazine Decanoate Regional Value Analysis
  1. 6.1 Global Fluphenazine Decanoate Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fluphenazine Decanoate Sales Value by Region (2021-2032)
  3. 6.2.1 Global Fluphenazine Decanoate Sales Value by Region: 2021-2026
  4. 6.2.2 Global Fluphenazine Decanoate Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Fluphenazine Decanoate Sales Value (2021-2032)
  7. 6.3.2 North America Fluphenazine Decanoate Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Fluphenazine Decanoate Sales Value (2021-2032)
  10. 6.4.2 Europe Fluphenazine Decanoate Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Fluphenazine Decanoate Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Fluphenazine Decanoate Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Fluphenazine Decanoate Sales Value (2021-2032)
  16. 6.6.2 South America Fluphenazine Decanoate Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Fluphenazine Decanoate Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Fluphenazine Decanoate Sales Value Share by Country, 2025 VS 2032
7 Fluphenazine Decanoate Country-level Value Analysis
  1. 7.1 Global Fluphenazine Decanoate Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Fluphenazine Decanoate Sales Value by Country (2021-2032)
  3. 7.2.1 Global Fluphenazine Decanoate Sales Value by Country (2021-2026)
  4. 7.2.2 Global Fluphenazine Decanoate Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Fluphenazine Decanoate Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Fluphenazine Decanoate Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Fluphenazine Decanoate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Atlantic Laboratories Corporation,Ltd.
  2. 8.1.1 Atlantic Laboratories Corporation,Ltd. Company Information
  3. 8.1.2 Atlantic Laboratories Corporation,Ltd. Business Overview
  4. 8.1.3 Atlantic Laboratories Corporation,Ltd. Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Atlantic Laboratories Corporation,Ltd. Fluphenazine Decanoate Product Portfolio
  6. 8.1.5 Atlantic Laboratories Corporation,Ltd. Recent Developments
  7. 8.2 AUROBINDO PHARMA LTD
  8. 8.2.1 AUROBINDO PHARMA LTD Company Information
  9. 8.2.2 AUROBINDO PHARMA LTD Business Overview
  10. 8.2.3 AUROBINDO PHARMA LTD Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AUROBINDO PHARMA LTD Fluphenazine Decanoate Product Portfolio
  12. 8.2.5 AUROBINDO PHARMA LTD Recent Developments
  13. 8.3 FRESENIUS KABI USA
  14. 8.3.1 FRESENIUS KABI USA Company Information
  15. 8.3.2 FRESENIUS KABI USA Business Overview
  16. 8.3.3 FRESENIUS KABI USA Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  17. 8.3.4 FRESENIUS KABI USA Fluphenazine Decanoate Product Portfolio
  18. 8.3.5 FRESENIUS KABI USA Recent Developments
  19. 8.4 MYLAN LABS LTD
  20. 8.4.1 MYLAN LABS LTD Company Information
  21. 8.4.2 MYLAN LABS LTD Business Overview
  22. 8.4.3 MYLAN LABS LTD Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  23. 8.4.4 MYLAN LABS LTD Fluphenazine Decanoate Product Portfolio
  24. 8.4.5 MYLAN LABS LTD Recent Developments
  25. 8.5 PAR STERILE PRODUCTS
  26. 8.5.1 PAR STERILE PRODUCTS Company Information
  27. 8.5.2 PAR STERILE PRODUCTS Business Overview
  28. 8.5.3 PAR STERILE PRODUCTS Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PAR STERILE PRODUCTS Fluphenazine Decanoate Product Portfolio
  30. 8.5.5 PAR STERILE PRODUCTS Recent Developments
  31. 8.6 WEST-WARD PHARMS INT
  32. 8.6.1 WEST-WARD PHARMS INT Company Information
  33. 8.6.2 WEST-WARD PHARMS INT Business Overview
  34. 8.6.3 WEST-WARD PHARMS INT Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  35. 8.6.4 WEST-WARD PHARMS INT Fluphenazine Decanoate Product Portfolio
  36. 8.6.5 WEST-WARD PHARMS INT Recent Developments
  37. 8.7 Shanghai Harvest Pharmaceutical
  38. 8.7.1 Shanghai Harvest Pharmaceutical Company Information
  39. 8.7.2 Shanghai Harvest Pharmaceutical Business Overview
  40. 8.7.3 Shanghai Harvest Pharmaceutical Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Harvest Pharmaceutical Fluphenazine Decanoate Product Portfolio
  42. 8.7.5 Shanghai Harvest Pharmaceutical Recent Developments
  43. 8.8 Shanghai Zhongxi Sunve Pharmaceutical
  44. 8.8.1 Shanghai Zhongxi Sunve Pharmaceutical Company Information
  45. 8.8.2 Shanghai Zhongxi Sunve Pharmaceutical Business Overview
  46. 8.8.3 Shanghai Zhongxi Sunve Pharmaceutical Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shanghai Zhongxi Sunve Pharmaceutical Fluphenazine Decanoate Product Portfolio
  48. 8.8.5 Shanghai Zhongxi Sunve Pharmaceutical Recent Developments
  49. 8.9 Southwest Pharmaceutical
  50. 8.9.1 Southwest Pharmaceutical Company Information
  51. 8.9.2 Southwest Pharmaceutical Business Overview
  52. 8.9.3 Southwest Pharmaceutical Fluphenazine Decanoate Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Southwest Pharmaceutical Fluphenazine Decanoate Product Portfolio
  54. 8.9.5 Southwest Pharmaceutical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst